Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 18;17(2):304-313.
doi: 10.5114/aoms.2019.83063. eCollection 2021.

Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management

Edyta Szymańska  1 , Dominika A Jóźwiak-Dzięcielewska  2 , Joanna Gronek  2 , Marta Niewczas  3 , Wojciech Czarny  4 , Dariusz Rokicki  1 , Piotr Gronek  2
Affiliations

Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management

Edyta Szymańska et al. Arch Med Sci. .

Abstract

Glycogen storage diseases (GSDs) are genetically determined metabolic diseases that cause disorders of glycogen metabolism in the body. Due to the enzymatic defect at some stage of glycogenolysis/glycogenesis, excess glycogen or its pathologic forms are stored in the body tissues. The first symptoms of the disease usually appear during the first months of life and are thus the domain of pediatricians. Due to the fairly wide access of the authors to unpublished materials and research, as well as direct contact with the GSD patients, the article addresses the problem of actual diagnostic procedures for patients with the suspected diseases. Knowledge and awareness of the problem among physicians seem insufficient, and research on the diagnosis and treatment of GSD is still ongoing, resulting in a heterogeneous GSD typology and a changing way of its diagnosis and treatment.

Keywords: glycogen storage disease; hepatomegaly; hypoglycemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Cascade of glycogen breakdown
Figure 2
Figure 2
Enzymatic activity of phosphorylase and synthase
See this image and copyright information in PMC

References

    1. Zhai L, Feng L, Xia L, Yin H, Xiang S. Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease – causing mutations. Nat Commun. 2016;7:11229. - PMC - PubMed
    1. Wang HF, Wu KH, Tsai CL. Neuroglycopenia in an euglycaemic patient under intensive insulin therapy. Anaesth Intensive Care. 2010;38:1137–8. - PubMed
    1. Joung-Hwan J, Streamson CC., Jr The brain – liver connection between BDNF and glucose control. Diabetes. 2013;62:1367–8. - PMC - PubMed
    1. Douillard C, Menton K, Dobbelaere D, Wemeau JL, Saudubray JM, Vantyghem MC. Hypoglycaemia related to inherited metabolic disease in adults. Orphanet J Rare Dis. 2012;7:26. - PMC - PubMed
    1. Moore MC, Katie C, Coate J, et al. Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr. 2012;3:286–94. - PMC - PubMed